GlassScriptPhysician profile
Paula K Figgs
NPI 1053416222
$6,031.13
in general payments reported to CMS, 2019-2025
37 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,125 · 2022: $1,185 · 2023: $864 · 2024: $1,200 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,622 · Education: $99.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,621.95 |
| Education | $99.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,201.18 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $536.74 | 2021-2025 | Nucala, Trelegy Ellipta |
| Biohaven Pharmaceuticals, INC. | $485.48 | 2021 | |
| Genzyme Corporation | $464.65 | 2021-2025 | |
| Optinose US, INC. | $456.77 | 2021-2025 | |
| Abbvie INC. | $414.87 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $340.84 | 2022 | |
| Pfizer INC. | $335.90 | 2022-2024 | |
| Lilly USA, LLC | $213.41 | 2023-2025 | Ebglyss, Zepbound, Olumiant |
| Genentech USA, INC. | $198.41 | 2024-2025 | Xolair |
| Lundbeck LLC | $195.96 | 2021-2024 | Vyepti |
| Biocryst US Sales Co., LLC | $156.73 | 2023-2025 | Orladeyo |
| Phathom Pharmaceuticals, INC. | $130.30 | 2024-2025 | Voquezna |
| Kaleo, INC. | $118.74 | 2021-2023 | Auvi-Q |
| Amgen INC. | $90.95 | 2021-2025 | Tezspire |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $74.15 | 2025 | Neffy |
| Hikma Pharmaceuticals USA | $54.36 | 2022-2023 | Ryaltris |
| Csl Behring | $48.31 | 2023-2024 | Haegarda |
| Teva Pharmaceuticals USA, INC. | $45.22 | 2021 | |
| Stryker Corporation | $44.42 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.91 | 2022-2025 | Takhzyro |
| Intersect Ent, INC. | $39.80 | 2022 | |
| Jazz Pharmaceuticals INC. | $38.34 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $35.23 | 2024-2025 | Airsupra |
| Supernus Pharmaceuticals, INC. | $31.54 | 2021 | |
| Welch Allyn | $29.80 | 2021 | |
| Novartis Pharmaceuticals Corporation | $28.29 | 2025 | |
| Phadia US INC. | $24.33 | 2022 | |
| Axsome Therapeutics, INC. | $23.75 | 2024 | Sunosi |
| Cochlear Americas | $21.09 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Integra Lifesciences Corporation | $19.06 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Pharming Healthcare, INC. | $16.94 | 2022 | |
| Paratek Pharmaceuticals, INC. | $15.69 | 2025 | Xhance, Nuzyra |
| Inspire Medical Systems, INC. | $14.96 | 2024 | Inspire |
| Alk-Abello, INC | $14.90 | 2021 | |
| Medtronic, INC. | $14.09 | 2024 | Nim Vital |
| Watermark Medical, INC. | $14.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Figgs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.